{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:30:15Z","timestamp":1760189415810},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T00:00:00Z","timestamp":1436572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00520-015-2834-2","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T04:21:53Z","timestamp":1436502113000},"page":"723-730","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim"],"prefix":"10.1007","volume":"24","author":[{"given":"H.","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. D.","family":"Vogl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,11]]},"reference":[{"key":"2834_CR1","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J et al (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106:2258\u20132266","journal-title":"Cancer"},{"key":"2834_CR2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3892\/etm.2011.312","volume":"2","author":"MB Schilling","year":"2011","unstructured":"Schilling MB, Parks C, Deeter RG (2011) Costs and outcomes associated with hospitalized cancer patients with neutropenic complications: a retrospective study. Exp Ther Med 2:859\u2013866","journal-title":"Exp Ther Med"},{"key":"2834_CR3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.6004\/jnccn.2008.0012","volume":"6","author":"J Crawford","year":"2008","unstructured":"Crawford J, Dale DC, Kuderer NM et al (2008) Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice. J Natl Compr Canc Netw 6:109\u2013118","journal-title":"J Natl Compr Canc Netw"},{"issue":"Suppl 1","key":"2834_CR4","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0959-8049(99)00259-2","volume":"36","author":"J Chang","year":"2000","unstructured":"Chang J (2000) Chemotherapy dose reduction and delay in clinical practice. Evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer. Eur J Cancer 36(Suppl 1):S11\u2013S14","journal-title":"Eur J Cancer"},{"key":"2834_CR5","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","volume":"25","author":"NM Kuderer","year":"2007","unstructured":"Kuderer NM, Dale DC, Crawford J, Lyman GH (2007) Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 25:3158\u20133167","journal-title":"J Clin Oncol"},{"key":"2834_CR6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.20.3.727","volume":"20","author":"FA Holmes","year":"2002","unstructured":"Holmes FA, O'Shaughnessy JA, Vukelja S et al (2002) Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III\/IV breast cancer. J Clin Oncol 20:727\u2013731","journal-title":"J Clin Oncol"},{"key":"2834_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/annonc\/mdg019","volume":"14","author":"MD Green","year":"2003","unstructured":"Green MD, Koelbl H, Baselga J et al (2003) A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy. Ann Oncol 14:29\u201335","journal-title":"Ann Oncol"},{"key":"2834_CR8","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/JCO.2005.09.102","volume":"23","author":"CL Vogel","year":"2005","unstructured":"Vogel CL, Wojtukiewicz MZ, Carroll RR et al (2005) First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study. J Clin Oncol 23:1178\u20131184","journal-title":"J Clin Oncol"},{"key":"2834_CR9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199107183250305","volume":"325","author":"J Crawford","year":"1991","unstructured":"Crawford J, Ozer H, Stoller R et al (1991) Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164\u2013170","journal-title":"N Engl J Med"},{"key":"2834_CR10","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Myeloid Growth Factors. Version 2.2013."},{"key":"2834_CR11","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","volume":"24","author":"TJ Smith","year":"2006","unstructured":"Smith TJ, Khatcheressian J, Lyman GH et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24:3187\u20133205","journal-title":"J Clin Oncol"},{"key":"2834_CR12","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","volume":"47","author":"MS Aapro","year":"2011","unstructured":"Aapro MS, Bohlius J, Cameron DA et al (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47:8\u201332","journal-title":"Eur J Cancer"},{"key":"2834_CR13","unstructured":"Neulasta\u00ae (pegfilgrastim) prescribing information, Amgen."},{"key":"2834_CR14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1548-5315(11)70402-8","volume":"7","author":"SA Gregory","year":"2010","unstructured":"Gregory SA, Schwartzberg LS, Mo M et al (2010) Evaluation of reported bone pain in cancer patients receiving chemotherapy in pegfilgrastim clinical trials: a retrospective analysis. Commun Oncol 7:297\u2013308","journal-title":"Commun Oncol"},{"key":"2834_CR15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1548-5315(11)70107-3","volume":"4","author":"JJ Kirshner","year":"2007","unstructured":"Kirshner JJ, Hickok J, Hofman M (2007) Pegfilgrastim-induced bone pain: incidence, risk factors, and management in a community practice. Commun Oncol 4:455\u2013459","journal-title":"Commun Oncol"},{"key":"2834_CR16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3816\/CBC.2003.n.003","volume":"3","author":"E Kubista","year":"2003","unstructured":"Kubista E, Glaspy J, Holmes FA et al (2003) Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer. Clin Breast Cancer 3:391\u2013398","journal-title":"Clin Breast Cancer"},{"key":"2834_CR17","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2011.37.8364","volume":"30","author":"JJ Kirshner","year":"2012","unstructured":"Kirshner JJ, Heckler CE, Janelsins MC et al (2012) Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base. J Clin Oncol 30:1974\u20131979","journal-title":"J Clin Oncol"},{"key":"2834_CR18","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/annonc\/mdf130","volume":"13","author":"FA Holmes","year":"2002","unstructured":"Holmes FA, Jones SE, O'Shaughnessy J et al (2002) Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer. Ann Oncol 13:903\u2013909","journal-title":"Ann Oncol"},{"key":"2834_CR19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1080\/1042819031000103953","volume":"44","author":"A Grigg","year":"2003","unstructured":"Grigg A, Solal-Celigny P, Hoskin P et al (2003) Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin\u2019s lymphoma. Leuk Lymphoma 44:1503\u20131508","journal-title":"Leuk Lymphoma"},{"key":"2834_CR20","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1182\/blood.V104.11.3311.3311","volume":"104","author":"A Lopez","year":"2004","unstructured":"Lopez A, Fernandez de Sevilla A, Castaigne S et al (2004) Pegfilgrastim supports delivery of CHOP-R chemotherapy administered every 14\u00a0days: a randomised phase II study. Blood 104:3311","journal-title":"Blood"},{"key":"2834_CR21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1200\/JCO.2003.03.040","volume":"21","author":"JM Vose","year":"2003","unstructured":"Vose JM, Crump M, Lazarus H et al (2003) Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma. J Clin Oncol 21:514\u2013519","journal-title":"J Clin Oncol"},{"key":"2834_CR22","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2000.18.13.2522","volume":"18","author":"E Johnston","year":"2000","unstructured":"Johnston E, Crawford J, Blackwell S et al (2000) Randomized, dose-escalation study of SD\/01 compared with daily filgrastim in patients receiving chemotherapy. J Clin Oncol 18:2522\u20132528","journal-title":"J Clin Oncol"},{"key":"2834_CR23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.critrevonc.2006.12.007","volume":"64","author":"G Romieu","year":"2007","unstructured":"Romieu G, Clemens M, Mahlberg R et al (2007) Pegfilgrastim supports delivery of FEC-100 chemotherapy in elderly patients with high risk breast cancer: a randomized phase 2 trial. Crit Rev Oncol Hematol 64:64\u201372","journal-title":"Crit Rev Oncol Hematol"},{"key":"2834_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3816\/CCC.2010.n.013","volume":"9","author":"JR Hecht","year":"2010","unstructured":"Hecht JR, Pillai M, Gollard R et al (2010) A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy. Clin Colorectal Cancer 9:95\u2013101","journal-title":"Clin Colorectal Cancer"},{"key":"2834_CR25","doi-asserted-by":"crossref","first-page":"A8173","DOI":"10.1200\/jco.2005.23.16_suppl.8173","volume":"23","author":"F Smith","year":"2005","unstructured":"Smith F, Kandahari M, Tomita D et al (2005) Neutropenia and anxiety in advanced non-small cell lung cancer (NSCLC) patients: initial report of a randomized controlled trial using pegfilgrastim to reduce neutropenia complications. J Clin Oncol 23:A8173","journal-title":"J Clin Oncol"},{"key":"2834_CR26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1634\/theoncologist.12-12-1416","volume":"12","author":"L Balducci","year":"2007","unstructured":"Balducci L, Al-Halawani H, Charu V et al (2007) Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim. Oncologist 12:1416\u20131424","journal-title":"Oncologist"},{"key":"2834_CR27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1200\/JOP.091094","volume":"6","author":"HA Burris","year":"2010","unstructured":"Burris HA, Belani CP, Kaufman PA et al (2010) Pegfilgrastim on the same day versus next day of chemotherapy in patients with breast cancer, non-small-cell lung cancer, ovarian cancer, and non-hodgkin\u2019s lymphoma: results of four multicenter, double-blind, randomized phase II studies. J Oncol Pract 6:133\u2013140","journal-title":"J Oncol Pract"},{"key":"2834_CR28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s12094-009-0453-4","volume":"11","author":"R Mattioli","year":"2009","unstructured":"Mattioli R, Gridelli C, Castellanos J et al (2009) Use of pegfilgrastim support on day 9 to maintain relative dose intensity of chemotherapy in breast cancer patients receiving a day 1 and 8 CMF regimen. Clin Transl Oncol 11:842\u2013848","journal-title":"Clin Transl Oncol"},{"key":"2834_CR29","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1080\/1042819031000063462","volume":"44","author":"S George","year":"2003","unstructured":"George S, Yunus F, Case D et al (2003) Fixed-dose pegfilgrastim is safe and allows neutrophil recovery in patients with non-Hodgkin\u2019s lymphoma. Leuk Lymphoma 44:1691\u20131696","journal-title":"Leuk Lymphoma"},{"key":"2834_CR30","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1080\/10428190600881017","volume":"47","author":"M Wolf","year":"2006","unstructured":"Wolf M, Bentley M, Marlton P et al (2006) Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin\u2019s lymphoma. Leuk Lymphoma 47:2344\u20132350","journal-title":"Leuk Lymphoma"},{"key":"2834_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00408-005-2594-8","volume":"184","author":"R Pirker","year":"2006","unstructured":"Pirker R, Ulsperger E, Messner J et al (2006) Achieving full-dose, on-schedule administration of ACE chemotherapy every 14\u00a0days for the treatment of patients with extensive small-cell lung cancer. Lung 184:279\u2013285","journal-title":"Lung"},{"key":"2834_CR32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2013.08.006","volume":"89","author":"M Lambertini","year":"2014","unstructured":"Lambertini M, Del Mastro L, Bellodi A, Pronzato P (2014) The five \"Ws\" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs). Crit Rev Oncol Hematol 89:112\u2013128","journal-title":"Crit Rev Oncol Hematol"},{"key":"2834_CR33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0749-0690(05)70079-3","volume":"17","author":"SJ Gibson","year":"2001","unstructured":"Gibson SJ, Helme RD (2001) Age-related differences in pain perception and report. Clin Geriatr Med 17:433\u2013456","journal-title":"Clin Geriatr Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2834-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-2834-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2834-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T21:32:29Z","timestamp":1599255149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-2834-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["2834"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-2834-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,11]]}}}